{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:27:47Z","timestamp":1776378467548,"version":"3.51.2"},"reference-count":91,"publisher":"Radcliffe Medical Media Ltd","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arrhythm Electrophysiol Rev"],"abstract":"<jats:p>The \u2018ablate-and-pace\u2019 strategy, combining atrioventricular junction ablation with permanent pacing, has re-emerged as a valuable therapeutic option for patients with AF who are symptomatic, have poor rate control or develop AF-mediated cardiomyopathy. While historically considered a last-resort treatment, recent randomised trials and meta-analyses support its efficacy in improving functional status, reducing hospitalisations and potentially enhancing survival, particularly when paired with CRT or conduction system pacing. The success of this approach depends on careful patient selection and appropriate device choice. Candidates include patients with uncontrolled ventricular rates, tachycardia\u2013bradycardia syndrome, symptomatic bradycardia or those with poor CRT response due to persistent AF. Right ventricular pacing should be avoided when possible, in favour of biventricular or conduction system pacing, which preserves synchrony and reduces pacing-induced cardiomyopathy. This review discusses clinical scenarios, prognostic considerations, and current device options \u2013 including leadless systems \u2013 offering a practical guide for tailoring atrioventricular junction ablation-based therapies to individual patient profiles.<\/jats:p>","DOI":"10.15420\/aer.2025.41","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:01:10Z","timestamp":1766142070000},"source":"Crossref","is-referenced-by-count":1,"title":["Determining Good Candidates for Atrioventricular Junction Ablation and Device Therapy and Which Device to Implant"],"prefix":"10.15420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3449-1800","authenticated-orcid":false,"given":"Arnaud","family":"Bisson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thibaut","family":"Lenormand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8803-7275","authenticated-orcid":false,"given":"Mathieu","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1658","authenticated-orcid":false,"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6096","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"ref0","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2024;45:3314\u2013414. https:\/\/doi.org\/10.1093\/eurheartj\/ehae176; PMID: 39210723."},{"key":"ref1","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics \u2013 2022 update: a report from the American Heart Association. Circulation 2022;145:e153\u2013e639. https:\/\/doi.org\/10.1161\/cir.0000000000001052; PMID: 35078371."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Shoureshi P, Tan AY, Koneru J, et al. Arrhythmia-induced cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2024;83:2214\u201332. https:\/\/doi.org\/10.1016\/j.jacc.2024.03.416; PMID: 38811098. DOI: 10.1016\/j.jacc.2024.03.416","DOI":"10.1016\/j.jacc.2024.03.416"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Gupta S, Figueredo VM. Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management. Int J Cardiol 2014;172:40\u20136. https:\/\/doi.org\/10.1016\/j.ijcard.2013.12.180; PMID: 24447747. DOI: 10.1016\/j.ijcard.2013.12.180","DOI":"10.1016\/j.ijcard.2013.12.180"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Shinbane JS, Wood MA, Jensen DN, et al. Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 1997;29:709\u201315. https:\/\/doi.org\/10.1016\/s0735-1097(96)00592-x; PMID: 9091514. DOI: 10.1016\/S0735-1097(96)00592-X","DOI":"10.1016\/S0735-1097(96)00592-X"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Tanaka R, Spinale FG, Crawford FA, Zile MR. Effect of chronic supraventricular tachycardia on left ventricular function and structure in newborn pigs. J Am Coll Cardiol 1992;20:1650\u201360. https:\/\/doi.org\/10.1016\/0735-1097(92)90462-v; PMID: 1452940. DOI: 10.1016\/0735-1097(92)90462-V","DOI":"10.1016\/0735-1097(92)90462-V"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Sasayama S, Asanoi H, Ishizaka S. Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs. Eur Heart J 1992;13(Suppl E):47\u201351. https:\/\/doi.org\/10.1093\/eurheartj\/13.suppl_e.47; PMID: 1478209. DOI: 10.1093\/eurheartj\/13.suppl_E.47","DOI":"10.1093\/eurheartj\/13.suppl_E.47"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Zile MR, Mukherjee R, Clayton C, et al. Effects of chronic supraventricular pacing tachycardia on relaxation rate in isolated cardiac muscle cells. Am J Physiol 1995;268:H2104\u201313. https:\/\/doi.org\/10.1152\/ajpheart.1995.268.5.H2104; PMID: 7771561. DOI: 10.1152\/ajpheart.1995.268.5.H2104","DOI":"10.1152\/ajpheart.1995.268.5.H2104"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Langer GA. Heart: excitation-contraction coupling. Annu Rev Physiol 1973;35:55\u201386. https:\/\/doi.org\/10.1146\/annurev.ph.35.030173.000415; PMID: 4196573. DOI: 10.1146\/annurev.ph.35.030173.000415","DOI":"10.1146\/annurev.ph.35.030173.000415"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Spinale FG, Tanaka R, Crawford FA, Zile MR. Changes in myocardial blood flow during development of and recovery from tachycardia-induced cardiomyopathy. Circulation 1992;85:717\u201329. https:\/\/doi.org\/10.1161\/01.cir.85.2.717; PMID: 1735164. DOI: 10.1161\/01.CIR.85.2.717","DOI":"10.1161\/01.CIR.85.2.717"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Riegger AJ, Liebau G. The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci (Lond) 1982;62:465\u20139. https:\/\/doi.org\/10.1042\/cs0620465; PMID: 7075144. DOI: 10.1042\/cs0620465","DOI":"10.1042\/cs0620465"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Spinale FG, Tomita M, Zellner JL, et al. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia. Am J Physiol 1991;261:H308\u201318. https:\/\/doi.org\/10.1152\/ajpheart.1991.261.2.H308; PMID: 1877659. DOI: 10.1152\/ajpheart.1991.261.2.H308","DOI":"10.1152\/ajpheart.1991.261.2.H308"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Mueller KAL, Heinzmann D, Klingel K, et al. Histopathological and immunological characteristics of tachycardia-induced cardiomyopathy. J Am Coll Cardiol 2017;69:2160\u201372. https:\/\/doi.org\/10.1016\/j.jacc.2017.02.049; PMID: 28449778. DOI: 10.1016\/j.jacc.2017.02.049","DOI":"10.1016\/j.jacc.2017.02.049"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Calderone A, Bouvier M, Li K, et al. Dysfunction of the beta- and alpha-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circ Res 1991;69:332\u201343. https:\/\/doi.org\/10.1161\/01.res.69.2.332; PMID: 1650296. DOI: 10.1161\/01.RES.69.2.332","DOI":"10.1161\/01.RES.69.2.332"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Marzo KP, Frey MJ, Wilson JR, et al. Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing. Circ Res 1991;69:1546\u201356. https:\/\/doi.org\/10.1161\/01.res.69.6.1546; PMID: 1659503. DOI: 10.1161\/01.RES.69.6.1546","DOI":"10.1161\/01.RES.69.6.1546"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Burchell SA, Spinale FG, Crawford FA, et al. Effects of chronic tachycardia-induced cardiomyopathy on the beta-adrenergic receptor system. J Thorac Cardiovasc Surg 1992;104:1006\u201312. https:\/\/doi.org\/10.1016\/S0022-5223(19)34685-9; PMID: 1328769. DOI: 10.1016\/S0022-5223(19)34685-9","DOI":"10.1016\/S0022-5223(19)34685-9"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Tanaka R, Fulbright BM, Mukherjee R, et al. The cellular basis for the blunted response to beta-adrenergic stimulation in supraventricular tachycardia-induced cardiomyopathy. J Mol Cell Cardiol 1993;25:1215\u201333. https:\/\/doi.org\/10.1006\/jmcc.1993.1134; PMID: 8263955. DOI: 10.1006\/jmcc.1993.1134","DOI":"10.1006\/jmcc.1993.1134"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Spinale FG, Tempel GE, Mukherjee R, et al. Cellular and molecular alterations in the beta adrenergic system with cardiomyopathy induced by tachycardia. Cardiovasc Res 1994;28:1243\u201350. https:\/\/doi.org\/10.1093\/cvr\/28.8.1243; PMID: 7954628. DOI: 10.1093\/cvr\/28.8.1243","DOI":"10.1093\/cvr\/28.8.1243"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"O\u2019Brien PJ, Moe GW, Nowack LM, et al. Sarcoplasmic reticulum Ca-release channel and ATP-synthesis activities are early myocardial markers of heart failure produced by rapid ventricular pacing in dogs. Can J Physiol Pharmacol 1994;72:999\u20131006. https:\/\/doi.org\/10.1139\/y94-139; PMID: 7842399. DOI: 10.1139\/y94-139","DOI":"10.1139\/y94-139"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"O\u2019Brien PJ, Ianuzzo CD, Moe GW, et al. Rapid ventricular pacing of dogs to heart failure: biochemical and physiological studies. Can J Physiol Pharmacol 1990;68:34\u20139. https:\/\/doi.org\/10.1139\/y90-004; PMID: 2328442. DOI: 10.1139\/y90-004","DOI":"10.1139\/y90-004"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Selby DE, Palmer BM, LeWinter MM, Meyer M. Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction. J Am Coll Cardiol 2011;58:147\u201354. https:\/\/doi.org\/10.1016\/j.jacc.2010.10.069; PMID: 21718911. DOI: 10.1016\/j.jacc.2010.10.069","DOI":"10.1016\/j.jacc.2010.10.069"},{"key":"ref21","unstructured":"Moe GW, Montgomery C, Howard RJ, et al. Left ventricular myocardial blood flow, metabolism, and effects of treatment with enalapril: further insights into the mechanisms of canine experimental pacing-induced heart failure. J Lab Clin Med 1993;121:294\u2013301. PMID: 8433042."},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Chen YC, Voskoboinik A, Gerche AL, et al. Prevention of pathological atrial remodeling and atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol 2021;77:2846\u201364. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.012; PMID: 34082914. DOI: 10.1016\/j.jacc.2021.04.012","DOI":"10.1016\/j.jacc.2021.04.012"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Mihm MJ, Yu F, Carnes CA, et al. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001;104:174\u201380. https:\/\/doi.org\/10.1161\/01.cir.104.2.174; PMID: 11447082. DOI: 10.1161\/01.CIR.104.2.174","DOI":"10.1161\/01.CIR.104.2.174"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Hoit BD, Takeishi Y, Cox MJ, et al. Remodeling of the left atrium in pacing-induced atrial cardiomyopathy. Mol Cell Biochem 2002;238:145\u201350. https:\/\/doi.org\/10.1023\/a:1019988024077; PMID: 12349902. DOI: 10.1023\/A:1019988024077","DOI":"10.1023\/A:1019988024077"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Schotten U, Ausma J, Stellbrink C, et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 2001;103:691\u20138. https:\/\/doi.org\/10.1161\/01.cir.103.5.691; PMID: 11156881. DOI: 10.1161\/01.CIR.103.5.691","DOI":"10.1161\/01.CIR.103.5.691"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Lip GYH, Laroche C, Popescu MI, et al. Heart failure in patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Pilot survey on atrial fibrillation. Eur J Heart Fail 2015;17:570\u201382. https:\/\/doi.org\/10.1002\/ejhf.254; PMID: 25727992. DOI: 10.1002\/ejhf.254","DOI":"10.1002\/ejhf.254"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Dickinson O, Chen LY, Francis GS. Atrial fibrillation and heart failure: intersecting populations, morbidities, and mortality. Heart Fail Rev 2014;19:285\u201393. https:\/\/doi.org\/10.1007\/s10741-013-9409-4; PMID: 24072593. DOI: 10.1007\/s10741-013-9409-4","DOI":"10.1007\/s10741-013-9409-4"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Patel RB, Vaduganathan M, Shah SJ, Butler J. Atrial fibrillation in heart failure with preserved ejection fraction: insights into mechanisms and therapeutics. Pharmacol Ther 2017;176:32\u20139. https:\/\/doi.org\/10.1016\/j.pharmthera.2016.10.019; PMID: 27773787. DOI: 10.1016\/j.pharmthera.2016.10.019","DOI":"10.1016\/j.pharmthera.2016.10.019"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Lenormand T, Bisson A, Fauchier L. Heart failure with preserved ejection fraction and atrial fibrillation. Minerva Med 2025;116:234\u201348. https:\/\/doi.org\/10.23736\/S0026-4806.25.09602-8; PMID: 40146046. DOI: 10.23736\/S0026-4806.25.09602-8","DOI":"10.23736\/S0026-4806.25.09602-8"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Qin D, Mansour MC, Ruskin JN, Heist EK. Atrial fibrillation-mediated cardiomyopathy. Circ Arrhythm Electrophysiol 2019;12:e007809. https:\/\/doi.org\/10.1161\/CIRCEP.119.007809; PMID: 31826649. DOI: 10.1161\/CIRCEP.119.007809","DOI":"10.1161\/CIRCEP.119.007809"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Reddy YNV, Borlaug BA, Gersh BJ. Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction. Circulation 2022;146:339\u201357. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.057444; PMID: 35877831. DOI: 10.1161\/CIRCULATIONAHA.122.057444","DOI":"10.1161\/CIRCULATIONAHA.122.057444"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Ozcan C, Li Z, Kim G, et al. Molecular mechanism of the association between atrial fibrillation and heart failure includes energy metabolic dysregulation due to mitochondrial dysfunction. J Card Fail 2019;25:911\u201320. https:\/\/doi.org\/10.1016\/j.cardfail.2019.08.005; PMID: 31415862. DOI: 10.1016\/j.cardfail.2019.08.005","DOI":"10.1016\/j.cardfail.2019.08.005"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Clark DM, Plumb VJ, Epstein AE, Kay GN. Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation. J Am Coll Cardiol 1997;30:1039\u201345. https:\/\/doi.org\/10.1016\/s0735-1097(97)00254-4; PMID: 9316536. DOI: 10.1016\/S0735-1097(97)00254-4","DOI":"10.1016\/S0735-1097(97)00254-4"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Gosselink AT, Blanksma PK, Crijns HJ, et al. Left ventricular beat-to-beat performance in atrial fibrillation: contribution of Frank-Starling mechanism after short rather than long RR intervals. J Am Coll Cardiol 1995;26:1516\u201321. https:\/\/doi.org\/10.1016\/0735-1097(95)00340-1; PMID: 7594079. DOI: 10.1016\/0735-1097(95)00340-1","DOI":"10.1016\/0735-1097(95)00340-1"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Billette J, Roberge FA, Nadeau RA. Roles of the AV junction in determining the ventricular response to atrial fibrillation. Can J Physiol Pharmacol 1975;53:575\u201385. https:\/\/doi.org\/10.1139\/y75-081; PMID: 1175086. DOI: 10.1139\/y75-081","DOI":"10.1139\/y75-081"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Kirchhof P, Camm AJ, Goette A, et al. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med 2020;383:1305\u201316. https:\/\/doi.org\/10.1056\/NEJMoa2019422; PMID: 32865375. DOI: 10.1056\/NEJMoa2019422","DOI":"10.1056\/NEJMoa2019422"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Gallagher JJ, Svenson RH, Kasell JH, et al. Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982;306:194\u2013200. https:\/\/doi.org\/10.1056\/NEJM198201283060402; PMID: 7054682. DOI: 10.1056\/NEJM198201283060402","DOI":"10.1056\/NEJM198201283060402"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Tan ES, Rienstra M, Wiesfeld ACP, et al. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation. Europace 2008;10:412\u20138. https:\/\/doi.org\/10.1093\/europace\/eun020; PMID: 18272509. DOI: 10.1093\/europace\/eun020","DOI":"10.1093\/europace\/eun020"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Chatterjee NA, Upadhyay GA, Ellenbogen KA, et al. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circ Arrhythm Electrophysiol 2012;5:68\u201376. https:\/\/doi.org\/10.1161\/CIRCEP.111.967810; PMID: 22187425. DOI: 10.1161\/CIRCEP.111.967810","DOI":"10.1161\/CIRCEP.111.967810"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Garcia B, Clementy N, Benhenda N, et al. Mortality after atrioventricular nodal radiofrequency catheter ablation with permanent ventricular pacing in atrial fibrillation: outcomes from a controlled nonrandomized study. Circ Arrhythm Electrophysiol 2016;9:e003993. https:\/\/doi.org\/10.1161\/CIRCEP.116.003993; PMID: 27363705. DOI: 10.1161\/CIRCEP.116.003993","DOI":"10.1161\/CIRCEP.116.003993"},{"key":"ref41","unstructured":"Chung MK, Patton KK, Lau CP, et al. 2023 HRS\/APHRS\/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm 2023;20:e17\u201391. https:\/\/doi.org\/10.1016\/j.hrthm.2023.03.1538; PMID: 37283271."},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Glikson M, Burri H, Abdin A, et al. European Society of Cardiology (ESC) clinical consensus statement on indications for conduction system pacing, with special contribution of the European Heart Rhythm Association of the ESC and endorsed by the Asia Pacific Heart Rhythm Society, the Canadian Heart Rhythm Society, the Heart Rhythm Society, and the Latin American Heart Rhythm Society. Europace 2025;27:euaf050. https:\/\/doi.org\/10.1093\/europace\/euaf050; PMID: 40159278. DOI: 10.1093\/europace\/euaf050","DOI":"10.1093\/europace\/euaf050"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 2021;42:3427\u2013520. https:\/\/doi.org\/10.1093\/eurheartj\/ehab364; PMID: 34455430. DOI: 10.1093\/eurheartj\/ehab699","DOI":"10.1093\/eurheartj\/ehab699"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Tops LF, Schalij MJ, Holman ER, et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48:1642\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2006.05.072; PMID: 17045901. DOI: 10.1016\/j.jacc.2006.05.072","DOI":"10.1016\/j.jacc.2006.05.072"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Brignole M, Pentimalli F, Palmisano P, et al. AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial. Eur Heart J 2021;42:4731\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehab569; PMID: 34453840. DOI: 10.1093\/eurheartj\/ehab569","DOI":"10.1093\/eurheartj\/ehab569"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Ousdigian KT, Borek PP, Koehler JL, et al. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality. Circ Arrhythm Electrophysiol 2014;7:370\u20136. https:\/\/doi.org\/10.1161\/CIRCEP.113.001212; PMID: 24838004. DOI: 10.1161\/CIRCEP.113.001212","DOI":"10.1161\/CIRCEP.113.001212"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Steinberg JS, Gorcsan J, Mazur A, et al. Junctional AV ablation in patients with atrial fibrillation undergoing cardiac resynchronization therapy (JAVA-CRT): results of a multicenter randomized clinical trial pilot program. J Interv Card Electrophysiol 2022;64:519\u201330. https:\/\/doi.org\/10.1007\/s10840-021-01116-6; PMID: 35043250. DOI: 10.1007\/s10840-021-01116-6","DOI":"10.1007\/s10840-021-01116-6"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Sanders P, Ariyaratnam JP, Puvrez A, et al. Cardiac resynchronization therapy and AV node ablation in heart failure with reduced ejection fraction and atrial fibrillation: rationale and design of the CAAN-AF trial. Heart Rhythm 2025. https:\/\/doi.org\/10.1016\/j.hroo.2025.07.018; epub ahead of press. DOI: 10.1016\/j.hroo.2025.07.018","DOI":"10.1016\/j.hroo.2025.07.018"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Sanders P. CAAN-AF: cardiac resynchronization therapy and AV node ablation in heart failure with reduced ejection fraction and atrial fibrillation. Presented at: ESC Congress 2025, Madrid, Spain, 29 August 2025. DOI: 10.1016\/j.hroo.2025.07.018","DOI":"10.1016\/j.hroo.2025.07.018"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Wilkoff BL, Cook JR, Epstein AE, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115\u201323. https:\/\/doi.org\/10.1001\/jama.288.24.3115; PMID: 12495391. DOI: 10.1001\/jama.288.24.3115","DOI":"10.1001\/jama.288.24.3115"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002;346:1854\u201362. https:\/\/doi.org\/10.1056\/NEJMoa013040; PMID: 12063369. DOI: 10.1056\/NEJMoa013040","DOI":"10.1056\/NEJMoa013040"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Yu CM, Chan JYS, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009;361:2123\u201334. https:\/\/doi.org\/10.1056\/NEJMoa0907555; PMID: 19915220. DOI: 10.1056\/NEJMoa0907555","DOI":"10.1056\/NEJMoa0907555"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Curtis AB, Worley SJ, Adamson PB, et al. Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 2013;368:1585\u201393. https:\/\/doi.org\/10.1056\/NEJMoa1210356; PMID: 23614585. DOI: 10.1056\/NEJMoa1210356","DOI":"10.1056\/NEJMoa1210356"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Kiehl EL, Makki T, Kumar R, et al. Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function. Heart Rhythm 2016;13:2272\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2016.09.027; PMID: 27855853. DOI: 10.1016\/j.hrthm.2016.09.027","DOI":"10.1016\/j.hrthm.2016.09.027"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160\u20135. https:\/\/doi.org\/10.1111\/j.1540-8167.2005.50062.x; PMID: 16302897. DOI: 10.1111\/j.1540-8167.2005.50062.x","DOI":"10.1111\/j.1540-8167.2005.50062.x"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Orlov MV, Gardin JM, Slawsky M, et al. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J 2010;159:264\u201370. https:\/\/doi.org\/10.1016\/j.ahj.2009.11.012; PMID: 20152225. DOI: 10.1016\/j.ahj.2009.11.012","DOI":"10.1016\/j.ahj.2009.11.012"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Jacobs M, Bodin A, Spiesser P, et al. Single-center experience of efficacy and safety of atrioventricular node ablation after left bundle branch area pacing for the management of atrial fibrillation. J Interv Card Electrophysiol 2024;67:1865\u201376. https:\/\/doi.org\/10.1007\/s10840-024-01847-2; PMID: 38913133. DOI: 10.1007\/s10840-024-01847-2","DOI":"10.1007\/s10840-024-01847-2"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Mittal S, Musat DL, Hoskins MH, et al. Clinical outcomes after ablation of the AV junction in patients with atrial fibrillation: impact of cardiac resynchronization therapy. J Am Heart Assoc 2017;6:e007270. https:\/\/doi.org\/10.1161\/JAHA.117.007270; PMID: 29180458. DOI: 10.1161\/JAHA.117.007270","DOI":"10.1161\/JAHA.117.007270"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Brignole M, Botto G, Mont L, et al. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Eur Heart J 2011;32:2420\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehr162; PMID: 21606084. DOI: 10.1093\/eurheartj\/ehr162","DOI":"10.1093\/eurheartj\/ehr162"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Stavrakis S, Garabelli P, Reynolds DW. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis. Europace 2012;14:1490\u20137. https:\/\/doi.org\/10.1093\/europace\/eus193; PMID: 22696519. DOI: 10.1093\/europace\/eus193","DOI":"10.1093\/europace\/eus193"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Brignole M, Pokushalov E, Pentimalli F, et al. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Eur Heart J 2018;39:3999\u20134008. https:\/\/doi.org\/10.1093\/eurheartj\/ehy555; PMID: 30165479. DOI: 10.1093\/eurheartj\/ehy555","DOI":"10.1093\/eurheartj\/ehy555"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Fang F, Sanderson JE, Yu CM. Should all patients with heart block receive biventricular pacing? All heart block patients with a pacemaker indication should receive biventricular pacing: one move, double the gains? Circ Arrhythm Electrophysiol 2015;8:722\u20139. https:\/\/doi.org\/10.1161\/CIRCEP.114.000626; PMID: 26082528. DOI: 10.1161\/CIRCEP.114.000626","DOI":"10.1161\/CIRCEP.114.000626"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"van Rees JB, de Bie MK, Thijssen J, et al. Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials. J Am Coll Cardiol 2011;58:995\u20131000. https:\/\/doi.org\/10.1016\/j.jacc.2011.06.007; PMID: 21867832. DOI: 10.1016\/j.jacc.2011.06.007","DOI":"10.1016\/j.jacc.2011.06.007"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Kirkfeldt RE, Johansen JB, Nohr EA, et al. Risk factors for lead complications in cardiac pacing: a population-based cohort study of 28,860 Danish patients. Heart Rhythm 2011;8:1622\u20138. https:\/\/doi.org\/10.1016\/j.hrthm.2011.04.014; PMID: 21699827. DOI: 10.1016\/j.hrthm.2011.04.014","DOI":"10.1016\/j.hrthm.2011.04.014"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Rijal S, Wolfe J, Rattan R, et al. Lead related complications in quadripolar versus bipolar left ventricular leads. Indian Pacing Electrophysiol J 2017;17:3\u20137. https:\/\/doi.org\/10.1016\/j.ipej.2016.10.008; PMID: 28401860. DOI: 10.1016\/j.ipej.2016.10.008","DOI":"10.1016\/j.ipej.2016.10.008"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Biffi M, Moschini C, Bertini M, et al. Phrenic stimulation: a challenge for cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2009;2:402\u201310. https:\/\/doi.org\/10.1161\/CIRCEP.108.836254; PMID: 19808496. DOI: 10.1161\/CIRCEP.108.836254","DOI":"10.1161\/CIRCEP.108.836254"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Landolina M, Gasparini M, Lunati M, et al. Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database. Circulation 2011;123:2526\u201335. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.015024; PMID: 21576653. DOI: 10.1161\/CIRCULATIONAHA.110.015024","DOI":"10.1161\/CIRCULATIONAHA.110.015024"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Chung ES, St John Sutton MG, Mealing S, et al. Economic value and cost-effectiveness of biventricular versus right ventricular pacing: results from the BLOCK-HF study. J Med Econ 2019;22:1088\u201395. https:\/\/doi.org\/10.1080\/13696998.2019.1652184; PMID: 31464176. DOI: 10.1080\/13696998.2019.1652184","DOI":"10.1080\/13696998.2019.1652184"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Herweg B, Mumtaz M, Vijayaraman P. Conduction system pacing for CRT: a physiological alternative. Arrhythm Electrophysiol Rev 2025;14:e04. https:\/\/doi.org\/10.15420\/aer.2024.10; PMID: 40017670. DOI: 10.15420\/aer.2024.10","DOI":"10.15420\/aer.2024.10"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Vijayaraman P, Subzposh FA, Naperkowski A. Atrioventricular node ablation and His bundle pacing. Europace 2017;19(Suppl 4):iv10\u20136. https:\/\/doi.org\/10.1093\/europace\/eux263; PMID: 29220422. DOI: 10.1093\/europace\/eux263","DOI":"10.1093\/europace\/eux263"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Vijayaraman P, Mathew AJ, Naperkowski A, et al. Conduction system pacing versus conventional pacing in patients undergoing atrioventricular node ablation: nonrandomized, on-treatment comparison. Heart Rhythm 2022;3:368\u201376. https:\/\/doi.org\/10.1016\/j.hroo.2022.04.005; PMID: 36097467. DOI: 10.1016\/j.hroo.2022.04.005","DOI":"10.1016\/j.hroo.2022.04.005"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Wang S, Wu S, Xu L, et al. Feasibility and efficacy of His bundle pacing or left bundle pacing combined with atrioventricular node ablation in patients with persistent atrial fibrillation and implantable cardioverter-defibrillator therapy. J Am Heart Assoc 2019;8:e014253. https:\/\/doi.org\/10.1161\/JAHA.119.014253; PMID: 31830874. DOI: 10.1161\/JAHA.119.014253","DOI":"10.1161\/JAHA.119.014253"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Xu L, Que D, Yu W, et al. His bundle pacing combined with atrioventricular node ablation for atrial fibrillation: a systematic review and meta-analysis. Expert Rev Med Devices 2024;21:1039\u201347. https:\/\/doi.org\/10.1080\/17434440.2024.2402561; PMID: 39268942. DOI: 10.1080\/17434440.2024.2402561","DOI":"10.1080\/17434440.2024.2402561"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Huang W, Wang S, Su L, et al. His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: a multicenter, randomized, crossover study-The ALTERNATIVE-AF trial. Heart Rhythm 2022;19:1948\u201355. https:\/\/doi.org\/10.1016\/j.hrthm.2022.07.009; PMID: 35843465. DOI: 10.1016\/j.hrthm.2022.07.009","DOI":"10.1016\/j.hrthm.2022.07.009"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Herbert J, Kovacsovics A, Brito R, et al. Mid-term performance of His bundle pacing and usefulness of backup leads. Europace 2024;26:euae168. https:\/\/doi.org\/10.1093\/europace\/euae168; PMID: 38874449. DOI: 10.1093\/europace\/euae168","DOI":"10.1093\/europace\/euae168"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Teigeler T, Kolominsky J, Vo C, et al. Intermediate-term performance and safety of His-bundle pacing leads: a single-center experience. Heart Rhythm 2021;18:743\u20139. https:\/\/doi.org\/10.1016\/j.hrthm.2020.12.031; PMID: 33418127. DOI: 10.1016\/j.hrthm.2020.12.031","DOI":"10.1016\/j.hrthm.2020.12.031"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Ding JW, Jiang YA, Wang QT. Left bundle branch area pacing prevails over His bundle pacing for heart failure patients undergoing atrioventricular node ablation in permanent atrial fibrillation: a network meta-analysis. J Interv Card Electrophysiol 2025;68:1363\u201372. https:\/\/doi.org\/10.1007\/s10840-025-02034-7; PMID: 40178725. DOI: 10.1007\/s10840-025-02034-7","DOI":"10.1007\/s10840-025-02034-7"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Bednarek A, Kie\u0142basa G, Moskal P, et al. Left bundle branch area pacing improves right ventricular function and synchrony. Heart Rhythm 2024;21:2234\u201341. https:\/\/doi.org\/10.1016\/j.hrthm.2024.05.019; PMID: 38750909. DOI: 10.1016\/j.hrthm.2024.05.019","DOI":"10.1016\/j.hrthm.2024.05.019"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Cai M, Wu S, Wang S, et al. Left bundle branch pacing postatrioventricular junction ablation for atrial fibrillation: propensity score matching with His bundle pacing. Circ Arrhythm Electrophysiol 2022;15:e010926. https:\/\/doi.org\/10.1161\/CIRCEP.122.010926; PMID: 36166683. DOI: 10.1161\/CIRCEP.122.010926","DOI":"10.1161\/CIRCEP.122.010926"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Kircanski B, Boveda S, Prinzen F, et al. Conduction system pacing in everyday clinical practice: EHRA physician survey. Europace 2023;25:682\u20137. https:\/\/doi.org\/10.1093\/europace\/euac201; PMID: 36413604. DOI: 10.1093\/europace\/euac201","DOI":"10.1093\/europace\/euac201"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Jastrz\u0119bski M, Huang W, Vazquez PM, Vijayaraman P. His bundle pacing in the era of left bundle branch pacing. Arrhythm Electrophysiol Rev 2025;14:e06. https:\/\/doi.org\/10.15420\/aer.2024.31; PMID: 40084344. DOI: 10.15420\/aer.2024.31","DOI":"10.15420\/aer.2024.31"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"El-Chami MF, Shinn T, Bansal S, et al. Leadless pacemaker implant with concomitant atrioventricular node ablation: experience with the Micra transcatheter pacemaker. J Cardiovasc Electrophysiol 2021;32:832\u201341. https:\/\/doi.org\/10.1111\/jce.14881; PMID: 33428248. DOI: 10.1111\/jce.14881","DOI":"10.1111\/jce.14881"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Reddy VY, Nair DG, Doshi SK, et al. First-in-human study of a leadless pacemaker system for left bundle branch area pacing. Heart Rhythm 2025;22:2010\u20137. https:\/\/doi.org\/10.1016\/j.hrthm.2025.04.030; PMID: 40300740. DOI: 10.1016\/j.hrthm.2025.04.030","DOI":"10.1016\/j.hrthm.2025.04.030"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Katritsis DG, Siontis KC, Agarwal S, et al. Anatomical ablation of the atrioventricular node. Arrhythm Electrophysiol Rev 2024;13:e12. https:\/\/doi.org\/10.15420\/aer.2024.13; PMID: 39221060. DOI: 10.15420\/aer.2024.13","DOI":"10.15420\/aer.2024.13"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Chaumont C, Azincot M, Savour\u00e9 A, et al. His bundle pacing versus left bundle branch area pacing in patients undergoing atrioventricular node ablation: a prospective and comparative study. Arch Cardiovasc Dis 2024;117:505\u201313. https:\/\/doi.org\/10.1016\/j.acvd.2024.05.118; PMID: 38981841. DOI: 10.1016\/j.acvd.2024.05.118","DOI":"10.1016\/j.acvd.2024.05.118"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Brignole M, Gianfranchi L, Menozzi C, et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation: a randomized controlled study. Circulation 1997;96:2617\u201324. https:\/\/doi.org\/10.1161\/01.cir.96.8.2617; PMID: 9355902. DOI: 10.1161\/01.CIR.96.8.2617","DOI":"10.1161\/01.CIR.96.8.2617"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Brignole M, Menozzi C, Gianfranchi L, et al. Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 1998;98:953\u201360. https:\/\/doi.org\/10.1161\/01.cir.98.10.953; PMID: 9737514. DOI: 10.1161\/01.CIR.98.10.953","DOI":"10.1161\/01.CIR.98.10.953"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Marshall HJ, Harris ZI, Griffith MJ, et al. Prospective randomized study of ablation and pacing versus medical therapy for paroxysmal atrial fibrillation: effects of pacing mode and mode-switch algorithm. Circulation 1999;99:1587\u201392. https:\/\/doi.org\/10.1161\/01.cir.99.12.1587; PMID: 10096935. DOI: 10.1161\/01.CIR.99.12.1587","DOI":"10.1161\/01.CIR.99.12.1587"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Brignole M, Gianfranchi L, Menozzi C, et al. Prospective, randomized study of atrioventricular ablation and mode-switching, dual chamber pacemaker implantation versus medical therapy in drug-resistant paroxysmal atrial fibrillation: tThe PAF study. Europace 1999;1:15\u20139. https:\/\/doi.org\/10.1053\/eupc.1998.0007; PMID: 11220531. DOI: 10.1053\/eupc.1998.0007","DOI":"10.1053\/eupc.1998.0007"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez Mu\u00f1oz D, Crespo-Leiro MG, Fern\u00e1ndez Lozano I, et al. Conduction system pacing and atrioventricular node ablation in heart failure: the PACE-FIB study design. ESC Heart Fail 2023;10:3700\u20139. https:\/\/doi.org\/10.1002\/ehf2.14488; PMID: 37731197. DOI: 10.1002\/ehf2.14488","DOI":"10.1002\/ehf2.14488"}],"container-title":["Arrhythmia &amp; Electrophysiology Review"],"original-title":[],"link":[{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2025.41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T10:38:04Z","timestamp":1766399884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerjournal.com\/articleindex\/aer.2025.41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":91,"URL":"https:\/\/doi.org\/10.15420\/aer.2025.41","relation":{},"ISSN":["2050-3369","2050-3377"],"issn-type":[{"value":"2050-3369","type":"print"},{"value":"2050-3377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"article-number":"e33"}}